{"title":"cac - probb在预测冠状动脉钙评分中的表现:一项在高cac负担人群中的外部验证研究。","authors":"Pakpoom Wongyikul, Phichayut Phinyo, Pannipa Suwannasom, Apichat Tantraworasin, Chanikan Srikuenkaew, Pichyapa Jira, Kempiya Pornpipatsakul, Arachaporn Ngachuea, Phansa Chanthanom, Kanogphol Prayongkul, Warisara Chavalitjiraphan, Thitirat Rattananalin, Surasak Saokaew","doi":"10.1186/s12911-025-03128-y","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Although CAC screening is gaining recognition in developing countries such as Thailand, official guidelines for using the CAC score in cardiovascular risk assessment remain lacking. This study aims to externally validate CAC-prob, a recently developed prediction model that can estimate the probability of CAC > 0 and CAC ≥ 100, to confirm its robustness.</p><p><strong>Method: </strong>This study externally validated the CAC-prob model using retrospective data from a tertiary care centre in northern Thailand. Patients who underwent CAC screening between 2019 and 2022 were included. CAC-prob consists of two models: one predicting the probability of CAC > 0 (Model 1) and another predicting the probability of CAC ≥ 100 (Model 2). Model performance was assessed in terms of discrimination (Ordinal C-index), calibration slope, and diagnostic indices for each model.</p><p><strong>Results: </strong>A total of 329 patients were included. The patient characteristics observed in this study indicated a higher prevalence of DM, hypertension, dyslipidaemia, CKD, and CAC ≥ 100 compared to the development study. The ordinal C-index derived from the validation study showed a slight decline (0.78). The calibration slope for Model 1 and Model 2 was 1.28 (95% CI 0.95-1.63) and 1.06 (95% CI 0.78-1.36), respectively. In Model 1, CAC-prob demonstrated comparable diagnostic performance. However, in Model 2, it showed slightly better performance, with significantly improved sensitivity compared to the development study.</p><p><strong>Conclusion: </strong>This external validation study confirms the predictive performance of CAC-prob in Northern Thai patients. The findings support the integration of CAC-prob into routine clinical practice to aid physicians in making recommendations for CAC screening.</p>","PeriodicalId":9340,"journal":{"name":"BMC Medical Informatics and Decision Making","volume":"25 1","pages":"288"},"PeriodicalIF":3.8000,"publicationDate":"2025-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12323013/pdf/","citationCount":"0","resultStr":"{\"title\":\"Performance of CAC-prob in predicting coronary artery calcium score: an external validation study in a high-CAC burden population.\",\"authors\":\"Pakpoom Wongyikul, Phichayut Phinyo, Pannipa Suwannasom, Apichat Tantraworasin, Chanikan Srikuenkaew, Pichyapa Jira, Kempiya Pornpipatsakul, Arachaporn Ngachuea, Phansa Chanthanom, Kanogphol Prayongkul, Warisara Chavalitjiraphan, Thitirat Rattananalin, Surasak Saokaew\",\"doi\":\"10.1186/s12911-025-03128-y\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Although CAC screening is gaining recognition in developing countries such as Thailand, official guidelines for using the CAC score in cardiovascular risk assessment remain lacking. This study aims to externally validate CAC-prob, a recently developed prediction model that can estimate the probability of CAC > 0 and CAC ≥ 100, to confirm its robustness.</p><p><strong>Method: </strong>This study externally validated the CAC-prob model using retrospective data from a tertiary care centre in northern Thailand. Patients who underwent CAC screening between 2019 and 2022 were included. CAC-prob consists of two models: one predicting the probability of CAC > 0 (Model 1) and another predicting the probability of CAC ≥ 100 (Model 2). Model performance was assessed in terms of discrimination (Ordinal C-index), calibration slope, and diagnostic indices for each model.</p><p><strong>Results: </strong>A total of 329 patients were included. The patient characteristics observed in this study indicated a higher prevalence of DM, hypertension, dyslipidaemia, CKD, and CAC ≥ 100 compared to the development study. The ordinal C-index derived from the validation study showed a slight decline (0.78). The calibration slope for Model 1 and Model 2 was 1.28 (95% CI 0.95-1.63) and 1.06 (95% CI 0.78-1.36), respectively. In Model 1, CAC-prob demonstrated comparable diagnostic performance. However, in Model 2, it showed slightly better performance, with significantly improved sensitivity compared to the development study.</p><p><strong>Conclusion: </strong>This external validation study confirms the predictive performance of CAC-prob in Northern Thai patients. The findings support the integration of CAC-prob into routine clinical practice to aid physicians in making recommendations for CAC screening.</p>\",\"PeriodicalId\":9340,\"journal\":{\"name\":\"BMC Medical Informatics and Decision Making\",\"volume\":\"25 1\",\"pages\":\"288\"},\"PeriodicalIF\":3.8000,\"publicationDate\":\"2025-08-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12323013/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"BMC Medical Informatics and Decision Making\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1186/s12911-025-03128-y\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"MEDICAL INFORMATICS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Medical Informatics and Decision Making","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12911-025-03128-y","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICAL INFORMATICS","Score":null,"Total":0}
引用次数: 0
摘要
背景:尽管CAC筛查在泰国等发展中国家得到认可,但在心血管风险评估中使用CAC评分的官方指南仍然缺乏。本研究旨在外部验证最近开发的预测模型CAC-prob,该模型可以估计CAC≥100和CAC≥100的概率,以验证其稳健性。方法:本研究使用泰国北部三级保健中心的回顾性数据,从外部验证了cac - probb模型。纳入了2019年至2022年期间接受CAC筛查的患者。CAC- probb由两个模型组成,一个预测CAC≥100的概率(模型1),另一个预测CAC≥100的概率(模型2)。根据每个模型的区分度(序数c指数)、校准斜率和诊断指标来评估模型的性能。结果:共纳入329例患者。本研究中观察到的患者特征表明,与发展研究相比,糖尿病、高血压、血脂异常、CKD和CAC≥100的患病率更高。验证研究得出的有序c指数略有下降(0.78)。模型1和模型2的校准斜率分别为1.28 (95% CI 0.95-1.63)和1.06 (95% CI 0.78-1.36)。在模型1中,cac - probb表现出相当的诊断性能。然而,在模型2中,它表现出稍好的性能,与开发研究相比,灵敏度明显提高。结论:这项外部验证研究证实了CAC-prob在泰国北部患者中的预测性能。研究结果支持将CAC- probb纳入常规临床实践,以帮助医生推荐CAC筛查。
Performance of CAC-prob in predicting coronary artery calcium score: an external validation study in a high-CAC burden population.
Background: Although CAC screening is gaining recognition in developing countries such as Thailand, official guidelines for using the CAC score in cardiovascular risk assessment remain lacking. This study aims to externally validate CAC-prob, a recently developed prediction model that can estimate the probability of CAC > 0 and CAC ≥ 100, to confirm its robustness.
Method: This study externally validated the CAC-prob model using retrospective data from a tertiary care centre in northern Thailand. Patients who underwent CAC screening between 2019 and 2022 were included. CAC-prob consists of two models: one predicting the probability of CAC > 0 (Model 1) and another predicting the probability of CAC ≥ 100 (Model 2). Model performance was assessed in terms of discrimination (Ordinal C-index), calibration slope, and diagnostic indices for each model.
Results: A total of 329 patients were included. The patient characteristics observed in this study indicated a higher prevalence of DM, hypertension, dyslipidaemia, CKD, and CAC ≥ 100 compared to the development study. The ordinal C-index derived from the validation study showed a slight decline (0.78). The calibration slope for Model 1 and Model 2 was 1.28 (95% CI 0.95-1.63) and 1.06 (95% CI 0.78-1.36), respectively. In Model 1, CAC-prob demonstrated comparable diagnostic performance. However, in Model 2, it showed slightly better performance, with significantly improved sensitivity compared to the development study.
Conclusion: This external validation study confirms the predictive performance of CAC-prob in Northern Thai patients. The findings support the integration of CAC-prob into routine clinical practice to aid physicians in making recommendations for CAC screening.
期刊介绍:
BMC Medical Informatics and Decision Making is an open access journal publishing original peer-reviewed research articles in relation to the design, development, implementation, use, and evaluation of health information technologies and decision-making for human health.